Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,520.00
(
0.33%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.45
(
-0.80%
)
Bitcoin
73,632.38
(
0.13%
)
News Focus
News Focus
Post# of 405226
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

sunspotter

Send PM Follow Ignore
Followers 226
Posts 17390
Boards Moderated 5
Alias Born 06/02/2007

sunspotter

Member Level

Re: williamssc post# 393984

Thursday, 10/06/2022 4:53:02 PM

Thursday, October 06, 2022 4:53:02 PM

Post# of 405226
“Brilacidin plus Caspofunginon cleared infection in the lungs by almost 95 percent, compared to ~50 percent when each compound was administered individually.”

Just so no one is given the false impression this study relates to humans, the lungs in question were those of immunosuppressed mice.

While this seems like progress - for some unfathomable reason it seems like no in vivo animal models were run for brilacidin in COVID19 - that’s a long way from proving efficacy in humans.

"The saddest lessons of history is this: If we’ve been conned long enough, we reject any evidence of the con. It’s too painful to acknowledge, even to ourselves, that we’ve been taken. if you give a charlatan power over you, you never get it back.”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote